No products in the cart.
Erdafitinib or Chemotherapy in Advanced Pre-Treated Urothelial Carcinoma
1. The median overall survival was 12.1 months in the erdafitinib group and 7.8 months in the chemotherapy group, with ...
- Specialties
- All Specialties, All Recent Reports
- Cardiology
- Chronic Disease
- Dermatology
- Emergency
- Endocrinology
- Gastroenterology
- Imaging and Intervention
- Infectious Disease
- Nephrology
- Neurology
- Obstetrics
- Oncology
- Ophthalmology
- Pediatrics
- Pharma
- Preclinical
- Psychiatry
- Public Health
- Pulmonology
- Rheumatology
- Surgery
- Tools
- Pharma
- AI News
- The Scan+
- Classics™+
- Rewinds
- Partners
- Account
- Specialties
- All Specialties, All Recent Reports
- Cardiology
- Chronic Disease
- Dermatology
- Emergency
- Endocrinology
- Gastroenterology
- Imaging and Intervention
- Infectious Disease
- Nephrology
- Neurology
- Obstetrics
- Oncology
- Ophthalmology
- Pediatrics
- Pharma
- Preclinical
- Psychiatry
- Public Health
- Pulmonology
- Rheumatology
- Surgery
- Tools
- Pharma
- AI News
- The Scan+
- Classics™+
- Rewinds
- Partners
- Account
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.